Ocupharm Research Group, Department of Optometry and Vision, Faculty of Optics and Optometry, Complutense University of Madrid, Madrid, Spain.
Ocupharm Research Group, Department of Optometry and Vision, Faculty of Optics and Optometry, Complutense University of Madrid, Madrid, Spain.
Cont Lens Anterior Eye. 2021 Dec;44(6):101471. doi: 10.1016/j.clae.2021.101471. Epub 2021 May 26.
To evaluate the changes in visual function and anterior surface aberrations during soft contact lens (SCL) wear after the instillation of hyaluronic acid (HA) eye drops with different viscosity.
A prospective, randomized, and participant-masked study was performed. Twenty healthy participants (25.4 ± 2.6 years) were evaluated. Hydrogel (Ocufilcon D) and silicone-hydrogel (Somofilcon A) SCL were randomly assigned to both eyes of the same participant. Visual function in terms of high- and low-contrast corrected distance visual acuity (CDVA) and anterior contact lens surface aberrations (RMS HOA) were measured before and after the instillation, at different times, of different eye drops: saline (control) and 0.1%, 0.2%, and 0.3% HA.
Compared with the saline solution, during hydrogel SCL wear, there was an improvement (P < 0.05) in high-contrast CDVA after 3 and 10 min with 0.1% HA, and after 5 and 20 min with 0.2% HA. During silicone-hydrogel SCL wear, there was a deterioration (P < 0.05) in high-contrast CDVA after 1 and 30 min with 0.3% HA. Additionally, during silicone-hydrogel SCL wear, there was also a deterioration (P < 0.05) in low-contrast CDVA after 5 and 20 min with 0.3% HA. In terms of RMS HOA, there were no clinically relevant changes with both SCL.
The instillation of HA eye drops could have a different effect on visual quality depending on their concentration of HA, the contact lens material, its surface ionicity, or other physicochemical properties that should be studied in future studies.
评估不同黏度的透明质酸钠(HA)滴眼液滴眼后软性隐形眼镜(SCL)佩戴过程中视觉功能和前表面像差的变化。
前瞻性、随机、参与者盲法研究。共评估 20 名健康参与者(25.4±2.6 岁)。将亲水型(Ocufilcon D)和硅水凝胶型(Somofilcon A)SCL 随机分配给同一参与者的双眼。在滴注不同的眼药水(生理盐水[对照]和 0.1%、0.2%和 0.3%HA)之前、之后以及不同时间,测量高对比度和低对比度矫正远视力(CDVA)和前接触镜表面像差(RMS 总像差)。
与生理盐水相比,在亲水型 SCL 佩戴期间,0.1%HA 在滴注后 3 和 10min 时,0.2%HA 在滴注后 5 和 20min 时,高对比度 CDVA 有改善(P<0.05)。在硅水凝胶型 SCL 佩戴期间,0.3%HA 在滴注后 1 和 30min 时,高对比度 CDVA 有下降(P<0.05)。此外,在硅水凝胶型 SCL 佩戴期间,0.3%HA 在滴注后 5 和 20min 时,低对比度 CDVA 也有下降(P<0.05)。在 RMS 总像差方面,两种 SCL 均无临床相关变化。
HA 滴眼液滴眼可能因其 HA 浓度、接触镜材料、表面离子性或其他物理化学特性的不同,对视觉质量产生不同的影响,这需要在未来的研究中进一步探讨。